Anders Wold, President and CEO, Clinical Care Solutions, GE Healthcare

Anders Wold

President and CEO, Clinical Care Solutions, GE Healthcare

The GE Vscan is among several point-of-care ultrasound systems being used to triage and monitor COVID-19 patients. I

The GE Vscan is among several point-of-care ultrasound systems being used to triage and monitor COVID-19 patients. 

COVID-19 is creating a new generation of cardiac patients.  With heart disease already the leading cause of deaths globally, this epidemic within a pandemic — a crisis within a crisis — creates a cardiology conundrum.

In all my years involved in healthcare, this is the most massive medical mystery I’ve encountered. The way patients are triaged, diagnosed, treated and monitored will forever change because of COVID-19.  Perhaps nowhere has that been more evident than in the field of cardiology.

Still in its infancy, the virus has layers upon layers of complexities, which have resulted in sometimes contrary observations and evidence about the impact it has on the heart.

In the early days, using ECG and ultrasound, clinicians in China reported signs of myocarditis and heart disease associated with COVID-19 patients. That data helped explain the spike in out-of-hospital cardiac arrests in the hard-hit northern region of Italy where Professor Luigi Badano, director of the cardiovascular imaging unit at Istituto Auxologico Italiano, IRCCS, and professor of cardiology at the University of Milano-Bicocca, uses strain imaging on ultrasound to understand the function of the right ventricle in predicting the prognosis of those patients who will survive the virus.

Currently, the United States surpasses 5 million recorded COVID-19 cases and record numbers of hospitalizations. New studies reinforce the earlier evidence suggesting that COVID-19 patients may have long term heart damage, while another study published by the American Heart Association (AHA) indicates suspected damage to the heart may not be myocarditis, but rather a unique pattern of cell death in scattered individual heart muscle cells. 

These observational studies, albeit small, are eye-opening and underscore the need for more research with larger sample sizes that will help draw solid conclusions to guide effective therapies and treatments. But the practice of medicine takes time, which is in short supply.

Hospitals have worked diligently to reassure patients that it’s not only safe, but important to seek medical care during the pandemic.  But, out of fear of contagion, many patients delay care.  As a med tech company with more than 40 years of experience in cardiology, we anticipate this delay puts patients with pre-existing cardiac conditions at even a greater risk of long-term harm, and additional burden on cardiologists as they manage care with new constraints.  At the same time, technology is opening the door for patient care to exist beyond the walls of the hospital, to manage patients on site and provide their caregivers with up-to-date information on their well-being.

When it comes to treating COVID-19 patients, clinicians globally are already using our technologies such as ECG to perform rapid first line diagnostic tests to identify cardiac emergencies and improve triage, and AI enabled ultrasound like a handheld device for automated, fast and objective ejection fraction measurement and a point-of-care ultrasound system that, in seconds, automates critical information needed by ER and ICU doctors to determine if the heart is pumping enough blood through the primary arteries to the organs.  As we look to the future, we will bring new technologies and solutions to the market that improve efficiency, productivity and clinical outcomes to meet the demands of this new world.

While these are puzzling times, the medical field continues to practice patience and perseverance — even as a rapidly spreading virus creates urgency on several fronts.  What we don’t know now won’t stop us from figuring it out. Let’s fix what we can, learn as we go and continue forging ahead, wherever it may lead us.

Editor's note: Anders Wold is president and CEO, clinical care solutions, at GE Healthcare. He is celebrating 22 years at GE Healthcare and nearly four decades working in healthcare, with most of his focus in cardiovascular ultrasound.


POCUS for COVID-19 and Cardiology Related Content:

DiA Imaging Analysis Receives Grant to Accelerate Access Ultrasound AI in Fight Against COVID-19

VIDEO: CT and POCUS Emerge As Frontline Cardiac Imaging Modalities in COVID-19 Era  — Interview with ith Geoffrey Rose, M.D.

VIDEO: GE AI-Assisted Automatic Ejection Fraction for Point-of-Care Ultrasound

FDA Clears Philips Ultrasound Portfolio to Image COVID-19 Related Lung and Cardiac Complications

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

VIDEO: Automated Cardiac Ejection Fraction for Point-of-care-ultrasound Using Artificial Intelligence

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction

GE Highlights New Echocardiography Technologies at ASE 2020

Related Content

Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
News | Cardiac Diagnostics

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Feature | Cardiac Diagnostics | By Kelly Patrick

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
News | Cardiac Diagnostics

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Subscribe Now